Werewolf Therapeutics
Biotechnology ResearchMassachusetts, United States11-50 Employees
We are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.
Insights
Gathering insights about Werewolf Therapeutics…
Similar companies to Werewolf Therapeutics
Checkmate Pharmaceuticals
35
Oncorus
51
$10M$50MFortress Biotech
21$10MKronos Bio
70$10M$50MGotham Therapeutics
2$10MPionyr Immunotherapeutics
51$10M$50MRibon Therapeutics
11$10MTvardi Therapeutics
19
Werewolf Therapeutics Tech Stack
Werewolf Therapeutics uses 8 technology products and services including SAS, NetSuite, ADP Workforce Now, and more. Explore Werewolf Therapeutics's tech stack below.
- SASBusiness Intelligence
- NetSuiteE-commerce
- ADP Workforce NowHuman Capital Management
- SmartsheetProject Management
- PaylocityRecruitment Marketing
- Adobe Tag ManagerTag Management
- Contact Form 7Web Platform Extensions
- NginxWeb Servers
Media & News
Werewolf Therapeutics's Email Address Formats
Werewolf Therapeutics uses at least 1 format(s):
| Werewolf Therapeutics Email Formats | Percentage |
| FLast@werewolftx.com | 50% |
| FLast@werewolftx.com | 50% |
Frequently Asked Questions
Where is Werewolf Therapeutics's headquarters located?
Werewolf Therapeutics's main headquarters is located at 200 Talcott Ave 2nd Floor Watertown, Massachusetts 02472 US. The company has employees across 3 continents, including North AmericaAsiaEurope. What is Werewolf Therapeutics's stock symbol?
Werewolf Therapeutics is a publicly traded company; the company's stock symbol is HOWL. What is Werewolf Therapeutics's official website and social media links?
Werewolf Therapeutics's official website is werewolftx.com and has social profiles on LinkedIn.How much revenue does Werewolf Therapeutics generate?
As of November 2024, Werewolf Therapeutics's annual revenue reached $3.8M. What is Werewolf Therapeutics's SIC code NAICS code?
Werewolf Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Werewolf Therapeutics have currently?
As of November 2024, Werewolf Therapeutics has approximately 49 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: R. I.Chief Technology Officer: C. K.Chief Scientific Officer: C. S.. Explore Werewolf Therapeutics's employee directory with LeadIQ.What industry does Werewolf Therapeutics belong to?
Werewolf Therapeutics operates in the Biotechnology Research industry. What technology does Werewolf Therapeutics use?
Werewolf Therapeutics's tech stack includes SASNetSuiteADP Workforce NowSmartsheetPaylocityAdobe Tag ManagerContact Form 7Nginx. What is Werewolf Therapeutics's email format?
Werewolf Therapeutics's email format typically follows the pattern of . Find more Werewolf Therapeutics email formats with LeadIQ. How much funding has Werewolf Therapeutics raised to date?
As of November 2024, Werewolf Therapeutics has raised $50M in funding. The last funding round occurred on May 10, 2022 for $50M.
Company Overview
- Headquarters
- 200 Talcott Ave 2nd Floor Watertown, Massachusetts 02472 US
- Website
- werewolftx.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- HOWL
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 11-50
Media & News
Funding & Financials
- $50M
Werewolf Therapeutics has raised a total of $50M of funding over 3 rounds. Their latest funding round was raised on May 10, 2022 in the amount of $50M.
- $10M
Werewolf Therapeutics's revenue is in the range of $10M
Funding & Financials
- $50M
Werewolf Therapeutics has raised a total of $50M of funding over 3 rounds. Their latest funding round was raised on May 10, 2022 in the amount of $50M.
- $10M
Werewolf Therapeutics's revenue is in the range of $10M
Company Leadership
R. I.Chief Medical Officer
C. K.Chief Technology Officer- C. S.Chief Scientific Officer
- D. W.Chief Legal Officer
E. L.Chief Business Officer And Head Of Investor Relations
Employee Directory
- E. L.Chief Business Officer And Head Of Investor Relations
- R. C.Executive Assistant To Chief Executive Officer
- R. L.Executive Assistant To Chief Executive Officer
- R. L.Chief Operating Officer
- P. W.Vp, Clinical Development Operations
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
